Andrei Kindzelski

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial”.

Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

The Lancet Diabetes & Endocrinology(2024)10.1016/s2213-8587(24)00218-3

N/A

0.449DataRank · unranked

13 citations

Sheryl L. Windsor, Orly Vardeny, Jeffrey S. Berger, Harmony R Reynolds, Stavroula Boumakis +75 more

Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trial

BMC Infectious Diseases(2023)10.1186/s12879-023-08295-9

N/A

0.113DataRank · unranked

1 citations

Scott C. Woller, Maria M. Brooks, Frank C. Sciurba, Jerry A. Krishnan, Deborah Martin +17 more

Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.14428

N/A

0DataRank · unranked

17 citations

Matthew D. Neal, Lucy Z. Kornblith, Michelle N. Gong, Harmony R. Reynolds, Mary Cushman +72 more

Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference

The Journal of Trauma: Injury, Infection, and Critical Care(2021)10.1097/ta.0000000000003300

N/A

0DataRank · unranked

32 citations

Nahed El Kassar, Andrew P. Cap, Andrei Kindzelski, Christopher S. Almond, Alan Barkun +14 more

Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization

UNC Libraries(2025)10.17615/vme9-c859

N/A

0DataRank · unranked

0 citations

Lisa Baumann Kreuziger, Annie Pennella, Nancy L. Shapiro, Alexandra Weissman, Deborah Siegal +25 more

Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial

Research and Practice in Thrombosis and Haemostasis(2023)10.1016/j.rpth.2023.102167

N/A

0DataRank · unranked

8 citations

Erinn M. Hade, Lucy Z. Kornblith, Lana A. Castellucci, Mary Cushman, Michael E. Farkouh +16 more

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

Bristol Research (University of Bristol)(2021)10.17863/cam.76384

N/A

0DataRank · unranked

589 citations

ACTIV-4a Investigators, REMAP-CAP Investigators, Matthew D. Neal, Bryan J. McVerry, José Carlos Nicolau +94 more